Inge G. Thulin

Inge G. Thulin has reported 355 sales at the main company of the record, nearly the whole file: 378 of the 384 filings concern that issuer (title: Chairman, President & CEO), the other 6 Chevron Corp (5) and Merck & Co., Inc. (1), both as Director. The sales total EUR 38,007,227, with a median of EUR 40,580: a very large number of small trades. The largest is dated January 31, 2018 (EUR 4,729,224), ahead of May 11, 2016 (EUR 1,548,031) and January 30, 2019 (EUR 1,300,002).

Two purchases exist, EUR 285,159 in total: EUR 240,365 at Merck & Co., Inc. on February 6, 2025 and EUR 44,794 at Chevron Corp on August 15, 2016. They make up 1% of the open-market trades. The record finally includes 21 share grants and 6 option exercises.

The filings, published between February 4, 2016 and February 7, 2025, break down as follows: 78 in 2016, 74 in 2017, 96 in 2018, 135 in 2019 and 1 in 2025. The median publication delay is 1 day. No filing falls in the last twelve months.

Trades by Thulin within 30 days of colleagues at 3M Co number 238, 162 and 162, every one in the same direction. Colleagues in order: Nicholas C. Gangestad, Michael F. Roman and Michael G. Vale.